N-methyl-D-aspartate receptor inhibition by an apolipoprotein E-derived peptide relies on low-density lipoprotein receptor-associated protein.
about
Apolipoprotein E-mimetics inhibit neurodegeneration and restore cognitive functions in a transgenic Drosophila model of Alzheimer's diseaseNeuroprotective pentapeptide CN-105 is associated with reduced sterile inflammation and improved functional outcomes in a traumatic brain injury murine model.An apolipoprotein E-mimetic stimulates axonal regeneration and remyelination after peripheral nerve injury.Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a reviewGlutamatergic model psychoses: prediction error, learning, and inferenceThe NMDA receptor functions independently and as an LRP1 co-receptor to promote Schwann cell survival and migration.LRP1 assembles unique co-receptor systems to initiate cell signaling in response to tissue-type plasminogen activator and myelin-associated glycoprotein.Apolipoprotein E mimetics and cholesterol-lowering properties.Signaling pathways of apoE and its role of gene expression in glomerulus diseases.Involvement of Mast Cells in α7 Nicotinic Receptor Agonist Exacerbation of Freund's Complete Adjuvant-Induced Monoarthritis in Mice.Neuroprotective pentapeptide CN-105 improves functional and histological outcomes in a murine model of intracerebral hemorrhageFull-length apolipoprotein E protects against the neurotoxicity of an apoE-related peptidePhase 1 Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety, Tolerability, and Pharmacokinetics of a Single Escalating Dose and Repeated Doses of CN-105 in Healthy Adult Subjects.
P2860
Q33517630-BC0BE2F8-FB89-4969-9EF4-D538C74CCD49Q33587711-D8BFB69B-51F8-4372-8A53-71E36720DB3DQ34028091-142A282B-27C2-434E-9E8E-86786BE3260DQ34238630-E92879B2-1224-4E23-937A-54438ADEB564Q34661231-9222C546-FB7D-4B91-AE44-574F3AE2B11CQ36125572-CD0D2982-6B79-4455-A9A5-B0345ACEF478Q37333802-E254B549-8719-4B14-A267-28CCE2412336Q37965590-75608B5B-BBFA-4E87-8CE3-ABD1B9B849EAQ38079285-FC35EDDC-9A87-4165-95E9-7F69CCA0BAC1Q38840251-3482C736-ADD1-4269-82FC-367F73C43DC7Q41360394-6EC57733-1F8D-4821-9F86-B5BD4C18383EQ41898440-0B7A907D-ACEF-4D83-BAF2-F547A5F4BC41Q48391156-A75354F2-FFA4-4AA2-BEFE-DE36792A3CFE
P2860
N-methyl-D-aspartate receptor inhibition by an apolipoprotein E-derived peptide relies on low-density lipoprotein receptor-associated protein.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
N-methyl-D-aspartate receptor ...... n receptor-associated protein.
@en
N-methyl-D-aspartate receptor ...... n receptor-associated protein.
@nl
type
label
N-methyl-D-aspartate receptor ...... n receptor-associated protein.
@en
N-methyl-D-aspartate receptor ...... n receptor-associated protein.
@nl
prefLabel
N-methyl-D-aspartate receptor ...... n receptor-associated protein.
@en
N-methyl-D-aspartate receptor ...... n receptor-associated protein.
@nl
P2093
P2860
P1433
P1476
N-methyl-D-aspartate receptor ...... n receptor-associated protein.
@en
P2093
Brigid E Brown
Francis J Castellino
Mary Prorok
Zhenyu Sheng
P2860
P304
P356
10.1016/J.NEUROPHARM.2008.05.016
P577
2008-05-24T00:00:00Z